Divi's Laboratories Q4 Results
- BSE: 532488
- NSE: DIVISLAB
- ISIN: INE361B01024
- Sector: Biotechnology & Drugs
BSE
8,446.20
-98.80 (-1.16%)
-98.80 (-1.16%)Volume27.72 K
Updated: Thu 13 Aug, 2026 | 11:23:54
NSE
8,430-170.00 (-1.98%)
-170.00 (-1.98%)Volume1.54 L
Updated: Thu 13 Aug, 2026 | 11:09:28
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Divi's Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 2,017.00 | 1,906.00 | 5.82% | 1,665.00 | 11.68% |
| Depreciation/ Amortization | 120.00 | 118.00 | 1.69% | 95.00 | 12.15% |
| Operating Income | 814.00 | 698.00 | 16.62% | 638.00 | 4.49% |
| Net Income | 751.00 | 583.00 | 28.82% | 538.00 | 13.44% |
| Other Operating Expenses Total | 397.00 | 402.00 | -1.24% | 371.00 | 7.88% |
| Net Income Before Taxes | 963.00 | 780.00 | 23.46% | 713.00 | 11.46% |
| Total Revenue | 2,831.00 | 2,604.00 | 8.72% | 2,303.00 | 9.52% |
| Selling/ General/ Admin Expenses Total | 381.00 | 367.00 | 3.81% | 297.00 | 8.86% |
| Diluted Normalized EPS | 28.30 | 24.07 | 17.58% | 20.24 | 13.49% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.